"Around the world, we’re now seeing an increase in the number of reported cases of #COVID19, especially in Europe and the Americas”, says @drtedros at @WHO presser. "Each of the last four days has been the highest number of cases reported so far."
@DrTedros@WHO "There has been some discussion recently about the concept of reaching so called herd immunity”, says @drtedros and gives the reasons why that is a bad idea: 1. immunity unclear 2. vast majority of people still susceptible 3. long term health impacts still unclear
@DrTedros@WHO “Allowing a dangerous virus that we don't fully understand to run free is simply unethical”, says @drtedros. "It's not an option."
@DrTedros@WHO "There are many tools at our disposal”, says @drtedros. “@WHO recommends
case finding, isolation, testing, compassionate care, contact tracing, quarantine, physical distancing, hand hygene, masks, respiratory etiquette, ventilation, avoiding crowds, and more."
@DrTedros@WHO "There are no shortcuts and no silver bullets, the answer is a comprehensive approach using every tool in the toolbox”, says @drtedros. Countries have done this successfully. "My message to every country now, weighing up its options is, you can do it too."
@DrTedros@WHO I asked about COVAX.
180 countries have now committed to the facility incl. the 92 countries that are eligible for GAVI support, says @doctorsoumya. “When you add up all of these countries, they represent 90% of the world's population."
@DrTedros@WHO@doctorsoumya "It looks like the COVAX facility really brought countries and people together”, says @doctorsoumya. “It sets a good example for for believing in and trying to achieve equitable access of vaccines."
@DrTedros@WHO@doctorsoumya Q about Brazil
“We are pleased to see the numbers stabilizing and going down in Brazil”, says @DrMikeRyan. “But remember, they're stabilizing and going down from some very very high numbers, and there are still many people getting #COVID19 in Brazil and across the Americas."
@DrTedros@WHO@doctorsoumya@DrMikeRyan “The fact that disease is on the way down does not mean that disease will not pick up again, and very very quickly in certain circumstances”, says @DrMikeRyan. "So we need to remain vigilant in all countries."
@DrTedros@WHO@doctorsoumya@DrMikeRyan We all remain humbled by how little we know about the virus, says @mvankerkhove. “But we know a heck of a lot more than we did a few months ago.” Says the knowledge is empowering: “What we are doing is having an effect. What we are doing is saving lives.”
@DrTedros@WHO@doctorsoumya@DrMikeRyan@mvankerkhove Q about infections rising in Europe but hospitalisations less so @DrMikeRyan: likely many factors at play, including the time lag between infections and hospitalizations and the fact that younger people are more affected at the moment and more testing means more mild cases found.
@DrTedros@WHO@doctorsoumya@DrMikeRyan@mvankerkhove Social distancing and masks may also lead to people being infected to lower infectious dose, says @DrMikeRyan. “That is something that's still very very speculative, something that will be explored and is being explored as we speak"
@DrTedros@WHO@doctorsoumya@DrMikeRyan@mvankerkhove "I think we need to be really careful right now not to make an assumption” that disconnect between infections and hospitalisations will stay that way, says @DrMikeRyan. “That could reconnect very very badly and very catastrophically unless we're very, very careful."
@DrTedros@WHO@doctorsoumya@DrMikeRyan@mvankerkhove Q about elections during pandemic
“It's possible to manage them, and reduce risk to an absolute minimum if everybody participates and if everybody adheres to what is an agreed method and agreed practice”, says @DrMikeRyan. “Problem very often is when those practices are ignored."
@DrTedros@WHO@doctorsoumya@DrMikeRyan@mvankerkhove “We're working right now on finalizing specific guidance for countries who choose in person elections, learning from the last eight nine months as to what has worked in those circumstances”, says @DrMikeRyan. Will be issuing that guidance in the coming days.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
So Trump is now also receiving dexamethasone. @WHO guidelines very clear that it is to be used only “in patients with severe and critical #COVID19”. Guidelines incl. “conditional recommendation not to use corticosteroid therapy in patients with non-severe #COVID19”.
Idea is not to reduce the immune system’s ability to fight the virus. But in later stages of severe disease, it’s the immune system itself that is creating most of the damage so sensible to dampen it down. Wondering if idea is that infused antibodies change that equation?
"We mourn the loss of so many”, says @DrTedros at #covid19@WHO presser. "The world is still grappling with the #COVID19 pandemic. Every week we’re adding approximately two million cases."
@DrTedros@WHO "It's never too late to turn the tide”, says @drtedros.
"In Europe, countries have done it. In Asia, countries have done it. In the Pacific, countries have done it. In the Middle East, countries have done it. In Africa, many countries have done it. In the Americas..."
@DrTedros@WHO "This is a critical moment in the #COVID19 outbreak response”, says @drtedros.
"We urge every single leader to strengthen their response, put targeted measures in place that we know can suppress the spread, ensure that health systems and workers are protected, and saves lives."
One million people dead from #covid19.
Imagine losing a mother, a father, a sister, a brother. Multiply that loss, that pain by a thousand then multiply that again by a thousand. That’s what we are looking at.
What a sad day.
And as I have written before we are on track for 1,500,000 deaths by the end of the year.
Last week more than 2 million cases and more than 36,000 deaths were reported to @WHO, similar to the week before. #covid19 is continuing to cause disease and death at a staggering rate.
@WHO "The Eastern Mediterranean Region showed the greatest increase (9%) in cases in the past week, while the European Region reported a substantial rise in deaths, with a 9% increase compared to the previous week.”
“Last week we reached an important milestone in which, @WHO issued the first Emergency Use Listing for a quality antigen based rapid diagnostic test, and we expect other rapid tests to follow. ”, says @DrTedros at #covid19 presser.
@WHO@DrTedros Good news: 120 million of these tests will be made available to low- and middle-income countries, to "enable the expansion of testing, particularly in hard to reach areas that do not have lab facilities or enough trained health workers to carry out PCR tests”, says @DrTedros.
@WHO@DrTedros These tests are cheaper ("priced at a maximum of 5 US dollars per unit”) and faster (15-30 minutes) than PCR, says @DrTedros. "The quicker #COVID19 can be diagnosed, the quicker action can be taken to treat and isolate those with a virus and trace their contacts."
It makes a lot of good points about what data is needed to improve models that can guide exit strategies and has a good short discussion on herd immunity and incl. three challenges for even determining the herd immunity threshold:
1. “most of the quantities for calculating the threshold are not known precisely”, for instance how common immunity is or how long it lasts 2. even the value for R0 needs to be refined 3. Disease clustering lowers threshold but to know how much, more info on transmission needed
"So-called lockdowns and the impact on global travel and trade have already taken such a heavy toll”, says @DrTedros at @WHO#covid19 presser. "The global economy is expected to contract by trillions of dollars this year."
@DrTedros@WHO "Many countries have poured money into domestic stimulus packages”, says @DrTedros. "But these investments will not on their own address the root cause of the economic crisis – which is the disease that paralyses health systems, disrupts economies and drives fear and uncertainty“
@DrTedros@WHO Today, @WHO and partners are publishing strategy plan and investment case for scale-up phase of the ACT Accelerator, says @DrTedros.
Aims to deliver
- 2 billion doses of vaccine
- 245 million treatment courses
- 500 million tests
to low/middle income countries by end of 2021